Eur Rev Med Pharmacol Sci 2024; 28 (3): 862-862
DOI: 10.26355/eurrev_202402_35365

Retraction Note: MicroRNA-132 promotes neurons cell apoptosis and activates Tau phosphorylation by targeting GTDC-1 in Alzheimer’s disease

D.-Y. Liu, L. Zhang

Department of Pathophysiology, College of Basic Medical Sciences, Chongqing Medical University, Chong-qing, China


The article “MicroRNA-132 promotes neurons cell apoptosis and activates Tau phosphorylation by targeting GTDC-1 in Alzheimer’s disease”, by D.-Y. Liu and L. Zhang, published in Eur Rev Med Pharmacol Sci 2019; 23 (19): 8523-8532–DOI: 10.26355/eurrev_201910_19166–PMID: 31646584 has been retracted by the Editor in Chief.

A 2020 investigation by a third party evidenced doubts about the originality of the Western blot figures, which share a similar background, regularly spaced bands, and rounded edges as a set of published papers.

A report published by China’s Ministry of Science and Technology in 2022 affirmed that upon investigation, it was discovered that instances of proxy investment were present in this paper.

The Editor in Chief mistrusts the results and decided, therefore, to withdraw the manuscript for malpractice.

The corresponding authors did not respond to journal correspondence about the retraction of this article.

This article has been retracted. The Publisher apologizes for any inconvenience this may cause.

MicroRNA-132 promotes neurons cell apoptosis and activates Tau phosphorylation by targeting GTDC-1 in Alzheimer’s disease

Free PDF Download

To cite this article

D.-Y. Liu, L. Zhang
Retraction Note: MicroRNA-132 promotes neurons cell apoptosis and activates Tau phosphorylation by targeting GTDC-1 in Alzheimer’s disease

Eur Rev Med Pharmacol Sci
Year: 2024
Vol. 28 - N. 3
Pages: 862-862
DOI: 10.26355/eurrev_202402_35365

Publication History

Published online: 16 Feb 2024